Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.
Related Posts
Piper Sandler downgrades Boston Beer after disappointing Hard Mountain Dew rollout
Piper Sandler is lowering its growth targets on Boston Beer after a recently disappointing launch of Hard Mountain Dew.
Nvidia sees ‘remarkable’ influx of retail investor dollars as traders flock to AI darling
Everyday traders bought nearly $30 billion of Nvidia shares on net this year, Vanda data shows.
The Federal Reserve is trimming rates, and these higher-yielding assets could be called back soon
Investors may be paid a little more interest for buying brokered CDs with call provisions, but the high-yield bonanza may be coming to an end […]